For patients with biopsy GS 4+4 PCa and no other EAU high risk features, there is a high likelihood of risk reclassification if they have low Percentage of GS 4+4 cores to cancer bearing cores and a low PSMA PET/CT SUV max. The gene discussed is FOLH1; the disease is posterior cortical atrophy.